https://www.selleckchem.com/products/ipi-549.html
The aim of this study was to investigate the effects of lactobacilli strains in preventing the recurrences of vaginal candidiasis (VC) in 78 pregnant women with VC (lactobacilli, n = 39; placebo, n = 39) and the potential benefits on quality of life. The lactobacilli putative probiotic (SynForU-HerCare; two capsules/day of 9.5 log CFU/capsule) or placebo was administered for 8-weeks in a randomized, double-blind, and placebo-controlled study. Subjects were assessed for vaginal and gut health conditions at baseline, week-4 and week-8 via
Like
Comment
Share
